P Barton

发表

Investigating The Impact of Structural Changes In A Nice Single Technology Appraisal Cost-Effectiveness Model.

M F Alam, P Barton, M Monahan, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK.

P Barton, P. Barton, C. Hyde, 2005, Health technology assessment.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

P Aveyard, P Barton, M. Connock, 2008, Health technology assessment.

Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling

P Barton, N. Low, S. Bryan, 2006, Sexually Transmitted Infections.

The management of dyspepsia: a systematic review.

J Raftery, P Barton, D. Forman, 2000, Health technology assessment.

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.

P Barton, P. Barton, A. Burls, 2004, Health technology assessment.

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.

P Barton, M. Connock, P. Barton, 2011, Health technology assessment.

Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.

P Barton, P. Barton, S Bryan, 2009, Health technology assessment.

Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis

P Barton, A. Sutton, E. Rogozińska, 2014, British Journal of Cancer.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

P Barton, S. Bryan, S. Jowett, 2006, Health technology assessment.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

P Barton, P. Barton, A. Burls, 2004, Health technology assessment.

Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.

P Barton, P Glasziou, P. Glasziou, 2009, Health technology assessment.

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.

P Barton, P. Barton, A. Burls, 2002, Health technology assessment.